These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 7570971

  • 1. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK, Mak TW, Chan TH, Wang A, Lam CW, Lai KN.
    Transplantation; 1995 Oct 15; 60(7):652-6. PubMed ID: 7570971
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
    Knopp RH, Frohlich J, Jokubaitis LA, Dawson K, Broyles FE, Gomez-Coronado D.
    Am J Med; 1994 Jun 06; 96(6A):69S-78S. PubMed ID: 8017470
    [Abstract] [Full Text] [Related]

  • 3. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
    Holdaas H, Hartmann A, Stenstrøm J, Dahl KJ, Borge M, Pfister P.
    Am J Cardiol; 1995 Jul 13; 76(2):102A-106A. PubMed ID: 7604781
    [Abstract] [Full Text] [Related]

  • 4. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB, Roth D.
    Am J Cardiol; 1995 Jul 13; 76(2):107A-109A. PubMed ID: 7604782
    [Abstract] [Full Text] [Related]

  • 5. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.
    Türk S, Yildiz A, Tükek T, Akkaya V, Aras U, Türkmen A, Uras AR, Sever MS.
    Int Urol Nephrol; 2001 Jul 13; 32(4):713-6. PubMed ID: 11989571
    [Abstract] [Full Text] [Related]

  • 6. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH.
    Am J Cardiol; 1995 Jul 13; 76(2):129A-135A. PubMed ID: 7604788
    [Abstract] [Full Text] [Related]

  • 7. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL, Shifrin FA, Bartucci MR, Knauss TC, Schulak JA, Hricik DE.
    Ann Pharmacother; 1996 Dec 13; 30(12):1386-9. PubMed ID: 8968448
    [Abstract] [Full Text] [Related]

  • 8. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.
    Transplant Proc; 2004 Sep 13; 36(7):2141-4. PubMed ID: 15518777
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and muscle safety of fluvastatin in cyclosporine-treated cardiac and renal transplant recipients: an exercise provocation test.
    Schrama YC, Hené RJ, de Jonge N, Joles JA, Van Rijn HJ, Bär DR, Ververs TF, Van Tol A, Koomans HA.
    Transplantation; 1998 Nov 15; 66(9):1175-81. PubMed ID: 9825814
    [Abstract] [Full Text] [Related]

  • 10. Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia.
    Betteridge DJ, Durrington PN, Fairhurst GJ, Jackson G, McEwan MS, McInnes GT, Miller JP, Mir MA, Reckless JP, Rees-Jones DI.
    Am J Med; 1994 Jun 06; 96(6A):45S-54S. PubMed ID: 8017467
    [Abstract] [Full Text] [Related]

  • 11. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.
    Greten H, Beil FU, Schneider J, Weisweiler P, Armstrong VW, Keller C, Klör HU, von Hodenberg E, Weidinger G, Eskötter H.
    Am J Med; 1994 Jun 06; 96(6A):55S-63S. PubMed ID: 8017468
    [Abstract] [Full Text] [Related]

  • 12. Fluvastatin for dyslipoproteinemia, with or without concomitant chronic renal insufficiency.
    Lintott CJ, Scott RS, Bremer JM, Shand BI.
    Am J Cardiol; 1995 Jul 13; 76(2):97A-101A. PubMed ID: 7604809
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia: preliminary report.
    Knopp RH, Frolich JJ.
    Am J Cardiol; 1994 May 26; 73(14):39D-41D. PubMed ID: 8198023
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Alaupovic P.
    Am J Kidney Dis; 2002 Jan 26; 39(1):67-75. PubMed ID: 11774104
    [Abstract] [Full Text] [Related]

  • 15. Fluvastatin (Lescol) treatment of hyperlipidaemia in patients with renal transplants.
    Löcsey L, Asztalos L, Kincses Z, Balázs G.
    Int Urol Nephrol; 1997 Jan 26; 29(1):95-106. PubMed ID: 9203045
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW, Siekmeier R, Lattke P, Merz M, Mix C, Schüler S, Jaross W.
    J Cardiovasc Pharmacol Ther; 2001 Oct 26; 6(4):351-61. PubMed ID: 11907637
    [Abstract] [Full Text] [Related]

  • 17. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 26; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 18. Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients.
    Martínez-Castelao A, Grinyó JM, Fiol C, Castiñeiras MJ, Hurtado I, Gil-Vernet S, Serón D, Porta I, Miñarro A, Villarroya A, Alsina J.
    Kidney Int Suppl; 1999 Jul 26; 71():S231-4. PubMed ID: 10412785
    [Abstract] [Full Text] [Related]

  • 19. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.
    Smit JW, Jansen GH, de Bruin TW, Erkelens DW.
    Am J Cardiol; 1995 Jul 13; 76(2):126A-128A. PubMed ID: 7604787
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
    Leitersdorf E, Muratti EN, Eliav O, Peters TK.
    Am J Cardiol; 1995 Jul 13; 76(2):84A-88A. PubMed ID: 7604807
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.